1. Home
  2. BLRX vs DTCK Comparison

BLRX vs DTCK Comparison

Compare BLRX & DTCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • DTCK
  • Stock Information
  • Founded
  • BLRX 2003
  • DTCK 1999
  • Country
  • BLRX Israel
  • DTCK Singapore
  • Employees
  • BLRX N/A
  • DTCK N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • DTCK Farming/Seeds/Milling
  • Sector
  • BLRX Health Care
  • DTCK Industrials
  • Exchange
  • BLRX Nasdaq
  • DTCK Nasdaq
  • Market Cap
  • BLRX 17.0M
  • DTCK 19.6M
  • IPO Year
  • BLRX 2011
  • DTCK 2023
  • Fundamental
  • Price
  • BLRX $3.71
  • DTCK $0.79
  • Analyst Decision
  • BLRX Strong Buy
  • DTCK
  • Analyst Count
  • BLRX 2
  • DTCK 0
  • Target Price
  • BLRX $19.00
  • DTCK N/A
  • AVG Volume (30 Days)
  • BLRX 40.4K
  • DTCK 291.1K
  • Earning Date
  • BLRX 08-14-2025
  • DTCK 04-30-2025
  • Dividend Yield
  • BLRX N/A
  • DTCK N/A
  • EPS Growth
  • BLRX N/A
  • DTCK N/A
  • EPS
  • BLRX N/A
  • DTCK N/A
  • Revenue
  • BLRX $17,251,000.00
  • DTCK $132,369,000.00
  • Revenue This Year
  • BLRX N/A
  • DTCK N/A
  • Revenue Next Year
  • BLRX N/A
  • DTCK N/A
  • P/E Ratio
  • BLRX N/A
  • DTCK N/A
  • Revenue Growth
  • BLRX 1.19
  • DTCK N/A
  • 52 Week Low
  • BLRX $2.30
  • DTCK $0.40
  • 52 Week High
  • BLRX $32.26
  • DTCK $1.50
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 39.17
  • DTCK 43.51
  • Support Level
  • BLRX $3.58
  • DTCK $0.72
  • Resistance Level
  • BLRX $4.17
  • DTCK $0.92
  • Average True Range (ATR)
  • BLRX 0.27
  • DTCK 0.06
  • MACD
  • BLRX -0.01
  • DTCK -0.01
  • Stochastic Oscillator
  • BLRX 37.11
  • DTCK 30.40

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About DTCK Davis Commodities Limited

Davis Commodities Ltd is an agricultural commodity trading company based in Singapore, which specializes in the trading of three main categories of agricultural commodities, namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa, and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage, and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil, and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.

Share on Social Networks: